Journal of Anesthesia

, Volume 23, Issue 3, pp 436–438

Anesthetic management for ascending aorta replacement in a patient who refused autologous transfusion for religious reasons

  • Shinju Obara
  • Masayuki Nakagawa
  • Shinichiro Takahashi
  • Masahiko Akatu
  • Tsuyoshi Isosu
  • Masahiro Murakawa
Clinical Report


We report on the anesthetic management of a 69-year-old female Jehovah’s Witness undergoing cardiopulmonary bypass to replace the ascending aorta; the patient refused transfusion of stored autologous or allogeneic blood products for religious reasons. The strategy involved preoperative hematopoiesis with recombinant human erythropoietin and iron, intraoperative acute normovolemic hemodilution, the use of a cell-saver system, administration of high-dose tranexamic acid, controlled hypotension, avoidance of low body temperature, simplification of the surgery, and lower blood dilution during cardiopulmonary bypass.

Key words

Acute normovolemic hemodilution Cardiac anesthesia Jehovah’s Witness 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah’s Witnesses). Ann R Coll Surg Engl. 2005;87:3–14.PubMedCrossRefGoogle Scholar
  2. 2.
    Nakagawa M, Kikuchi K, Konishi A. Anesthetic management of ruptured abdominal aortic aneurysm under cardiopulmonary bypass in a Jehovah’s Witness patient (in Japanese with English abstract). J Clin Anesth (Jpn). 2002;26:1065–1068.Google Scholar
  3. 3.
    Henderson AM, Maryniak JK, Simpson JC. Cardiac surgery in Jehovah’s witnesses. A review of 36 cases. Anaesthesia. 1986;41:748–753.Google Scholar
  4. 4.
    Ott DA, Cooley DA. Cardiovascular surgery in Jehovah’s Witnesses. Report of 542 operations without blood transfusion. JAMA. 1977;238:1256–1258.PubMedCrossRefGoogle Scholar
  5. 5.
    Flom-Halvorsen HI, Ovrum E, Oystese R, Brosstad F. Quality of intraoperative autologous blood withdrawal used for retransfusion after cardiopulmonary bypass. Ann Thorac Surg. 2003;76:744–748.PubMedCrossRefGoogle Scholar
  6. 6.
    Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med. 1996;101:22S–27S.PubMedCrossRefGoogle Scholar
  7. 7.
    Greeley WJ, Steven JM, Nicolson SC. Anesthesia for pediatric cardiac surgery. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia: Elsevier; 2005. p. 2005–2049.Google Scholar
  8. 8.
    Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg. 2003;125:1438–1450.PubMedCrossRefGoogle Scholar
  9. 9.
    Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67:1053–1076.PubMedCrossRefGoogle Scholar
  10. 10.
    Mori M, Nishi S, Asada A. Pharmacokinetics and pharmacodynamics of olprinone after cardiac surgery. Osaka City Med J. 2004;50:1–8.PubMedGoogle Scholar
  11. 11.
    Yao FS, Tseng CC, Ho CY, Levin SK, Illner P. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:552–558.PubMedCrossRefGoogle Scholar
  12. 12.
    Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 1994;71:633–640.PubMedGoogle Scholar
  13. 13.
    Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol. 1991;38:113–119.PubMedCrossRefGoogle Scholar
  14. 14.
    Okuyama K, Matsukawa T, Abe F, Kumazawa T. Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 1998;47:861–864.Google Scholar
  15. 15.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg. 2000;120:520–527.PubMedCrossRefGoogle Scholar
  16. 16.
    Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–2331.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2009

Authors and Affiliations

  • Shinju Obara
    • 1
  • Masayuki Nakagawa
    • 1
  • Shinichiro Takahashi
    • 1
  • Masahiko Akatu
    • 1
  • Tsuyoshi Isosu
    • 1
  • Masahiro Murakawa
    • 1
  1. 1.Department of AnesthesiologyFukushima Medical University School of MedicineFukushimaJapan

Personalised recommendations